Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 418941011000036117 | glucose 50 g / 1 L + magnesium acetate tetrahydrate 320 mg / 1 L + potassium acetate 1.28 g / 1 L + sodium chloride 2.34 g / 1 L injection, 12 x 1 L bags (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 418942011000036111 | sodium chloride 2.34 g/L + potassium acetate 1.28 g (potassium 13 mmol)/L + magnesium acetate tetrahydrate 320 mg/L + glucose 5% (50 g/L) injection, 12 x 1 L bags | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| sodium chloride 2.34 g/L + potassium acetate 1.28 g (potassium 13 mmol)/L + magnesium acetate tetrahydrate 320 mg/L + glucose 5% (50 g/L) injection, 12 x 1 L bags | Is a | glucose 5% (50 g/L) injection, 12 x 1 L bags | true | Inferred relationship | Some | ||
| sodium chloride 2.34 g/L + potassium acetate 1.28 g (potassium 13 mmol)/L + magnesium acetate tetrahydrate 320 mg/L + glucose 5% (50 g/L) injection, 12 x 1 L bags | has MPUU | sodium chloride 2.34 g/L + potassium acetate 1.28 g (potassium 13 mmol)/L + magnesium acetate tetrahydrate 320 mg/L + glucose 5% (50 g/L) injection, bag | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Plasma-Lyte 56 Maintenance in 5% Glucose injection, 12 x 1 L bags | Is a | True | sodium chloride 2.34 g/L + potassium acetate 1.28 g (potassium 13 mmol)/L + magnesium acetate tetrahydrate 320 mg/L + glucose 5% (50 g/L) injection, 12 x 1 L bags | Inferred relationship | Some |
Reference Sets
List of Excluded Medicinal Items reference set
Medicinal product pack reference set
FHIR